The FTSE 100 index climbed 10 points to 4,196 this morning after AstraZenica received US Food and Dr...
The FTSE 100 index climbed 10 points to 4,196 this morning after AstraZenica received US Food and Drug Administration approval for Crestor branded cholesterol drug. AstraZenica led the gainers with a 66p rise to £25.55. Dixons continued its rise on the back of strong sales caused by hot weather, adding another 2.75p to 133.75p. AngloAmerica added 20p to 1160.5p as South African-based companies saw share prices soar to six-month highs on hopes that global economic recovery will increase demand for metals such as gold and platinum. Scottish & Newcastle dropped 20.2...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
